Neurology

Tuesday, September 15, 2026

1

IVIG Plus Prednisone Improves Early Myositis Response

2

Febrile Seizures Associated With Minimal Differences in School Performance

Monday, September 14, 2026

1

FDA Approves Isembyld to Target Muscle Loss in Spinal Muscular Atrophy

Friday, September 11, 2026

1

Loberamisal Improved 90-Day Function After Ischemic Stroke

Thursday, September 10, 2026

1

B-Cell–Depleting Therapy Linked to Fewer Relapses in Early MS

Wednesday, September 09, 2026

1

Liberal Transfusions Linked to Better Outcomes After Traumatic Brain Injury

Friday, September 04, 2026

1

FDA Approves First Treatment for Alexander Disease

2

Maternal COVID-19 Not Associated With Child Neurological Disorders

Thursday, September 03, 2026

1

HLA-A*32:01 Linked to Lamotrigine-Induced DRESS

Wednesday, September 02, 2026

1

Remibrutinib Reduced Relapses in Phase 3 Relapsing MS Trials

2

Higher Semaglutide Dose Linked to Fewer Neuropsychiatric Diagnoses

Tuesday, September 01, 2026

1

Statin Timing Linked to Dementia Risk After Diabetes Diagnosis

2

Intensive Blood Pressure Control Cuts Dementia Risk Over 7 Years

3

Updated Guideline Guides Migraine Prevention Drug Selection

Friday, August 28, 2026

1

First Oral Dermatomyositis Treatment Approved

Thursday, August 27, 2026

1

Left Atrial Appendage Closure Linked to Higher Ischemic Stroke Risk

Tuesday, August 25, 2026

1

GLP-1–Metformin Therapy Linked to Fewer Cognitive Disorders

Friday, August 21, 2026

1

FDA Clears Wearable Parkinson Monitoring Platform

Thursday, August 20, 2026

1

Phase 3 MINT Analysis Finds Lower Exacerbation and Rescue Therapy Risk With Inebilizumab in gMG

2

FDA Seeks Input on Oversight of Generative AI-Enabled Medical Devices

Loading